Tekla Capital Management LLC Epizyme, Inc. Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 13, 2020	SELL	$11.73 - $16.25 $2.44 Million - $3.38 Million	-207,752 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$14.83 - $26.72 $2.16 Million - $3.88 Million	-145,350 Reduced 41.16%	207,752 $3.22 Million
Q4 2019 Feb 13, 2020	SELL	$9.77 - $24.6 $454,324 - $1.14 Million	-46,502 Reduced 11.64%	353,102 $8.69 Million
Q2 2019 Aug 14, 2019	BUY	$11.43 - $15.12 $1.26 Million - $1.67 Million	110,200 Added 38.08%	399,604 $5.02 Million
Q1 2019 May 14, 2019	SELL	$5.98 - $13.98 $576,878 - $1.35 Million	-96,468 Reduced 25.0%	289,404 $3.59 Million
Q4 2018 Feb 13, 2019	SELL	$5.22 - $10.44 $519,144 - $1.04 Million	-99,453 Reduced 20.49%	385,872 $2.38 Million
Q1 2018 May 14, 2018	BUY	$12.5 - $19.75 $366,562 - $579,168	29,325 Added 6.43%	485,325 $8.62 Million
Q3 2017 Nov 13, 2017	BUY	$12.7 - $19.25 $2.22 Million - $3.37 Million	175,000 Added 62.28%	456,000 $8.69 Million
Q2 2017 Aug 14, 2017	BUY	N/A	281,000	281,000 $4.24 Million

About Epizyme, Inc.

Ticker EPZM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 168,364,992
Market Cap $247M

More about EPZM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.